CHMP’s February 2024 Meeting: New Drug Re...

By HEOR Staff Writer

February 24, 2024

Introduction: The Committee for Medicinal Products for Human Use (CHMP) held its February 2024 meeting with numerous noteworthy outcomes. CHMP assessments are based on extensive scientific data analysis. They assess
A Look at Saudi Arabia’s Pharmaceutical Market in 2024
Value-Based Medication Benefits in Diabetes Management
Mobile Digital Health Platforms Use in TAVR
The Future of Medical Innovations: New Tools and Programs
Unmasking Chronic Kidney Disease and Economic Implications
The Economic Burden of Early-Stage Chronic Kidney Disease in Japan
A Potential Solution for Acute Heart Failure Hospitalisation
Direct Oral Anticoagulants Efficacy Versus Vitamin K Antagonists
Sanofi’s Vision: Bolstering Access to Innovation in Morocco’s Hea...
The Dawn of a New Era: Deep Learning in Cardiovascular Imaging
The Power of Telehealth and CGM Technology in Diabetes Management
Hypertension Management by Pharmacist Interventions